Literature DB >> 8615006

Infectivity and host responses in Creutzfeldt-Jakob disease.

L Manuelidis1, W Fritch.   

Abstract

The relationship between viral titer and host responses was evaluated in Creutzfeldt-Jakob Disease (CJD). Rapid clearing of 97% of the virus from hamster brain occurred within 5 days, and residual virus was dispersed equally to both hemispheres. Exponential replication began only after a long eclipse phase of approximately 30 days, and by 100 days showed an > 3 log increase in titer. However, from 100 to 135 days, titers were restricted to plateau levels of approximately 10(8)/g. In comparison, previous studies show no appreciable eclipse phase and > or = 100-fold higher brain titers in hamster scrapie. Our calculations also revealed an effective doubling time (ti) of 7.6 days in CJD and a markedly different ti of approximately 3 days in scrapie. Thus different initiation and replication programs are encoded by each of these strains. The most pertinent host molecular responses included early astrocytic activity by 54 days, unaccompanied by morphological or behavioral changes. Changes in host PrP were minimal until 87 days when titers were already 2 x 10(7)/g. In the next 20 days 60% of brain PrP became resistant to limited proteolysis but total PrP did not increase. These fulminant PrP changes preceded viral arrest and subsequent spongiform degeneration. Because these and other data are not consistent with PrP itself being the infectious agent, we discuss a model in which progressive PrP and glial activation are part of a final host strategy to contain a virus that is innocuous at low titers. This strategy is flawed because PrP is an independent provocateur of self-destruction in the brain. However, in the periphery this strategy may eliminate rare infected cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8615006     DOI: 10.1006/viro.1996.0033

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  24 in total

1.  Neuroinvasion by a Creutzfeldt-Jakob disease agent in the absence of B cells and follicular dendritic cells.

Authors:  M J Shlomchik; K Radebold; N Duclos; L Manuelidis
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

2.  Follicular dendritic cells and dissemination of Creutzfeldt-Jakob disease.

Authors:  L Manuelidis; I Zaitsev; P Koni; Z Y Lu; R A Flavell; W Fritch
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Theoretical modeling of prion disease incubation.

Authors:  R V Kulkarni; A Slepoy; R R P Singh; D L Cox; F Pázmándi
Journal:  Biophys J       Date:  2003-08       Impact factor: 4.033

4.  Virus-like interference in the latency and prevention of Creutzfeldt-Jakob disease.

Authors:  Laura Manuelidis; Zhi Yun Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-11       Impact factor: 11.205

5.  Agent-specific Shadoo responses in transmissible encephalopathies.

Authors:  Kohtaro Miyazawa; Laura Manuelidis
Journal:  J Neuroimmune Pharmacol       Date:  2010-01-30       Impact factor: 4.147

6.  Contact-induced structure transformation in transmembrane prion propagation.

Authors:  D-M Ou; C-C Chen; C-M Chen
Journal:  Biophys J       Date:  2007-01-26       Impact factor: 4.033

7.  A rapid accurate culture assay for infectivity in Transmissible Encephalopathies.

Authors:  Ying Liu; Ru Sun; Trisha Chakrabarty; Laura Manuelidis
Journal:  J Neurovirol       Date:  2008-11-12       Impact factor: 2.643

8.  Proteomic analysis of host brain components that bind to infectious particles in Creutzfeldt-Jakob disease.

Authors:  Terry Kipkorir; Christopher M Colangelo; Laura Manuelidis
Journal:  Proteomics       Date:  2015-06-09       Impact factor: 3.984

9.  Vaccination with an attenuated Creutzfeldt-Jakob disease strain prevents expression of a virulent agent.

Authors:  L Manuelidis
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

10.  Quantitative recovery of scrapie agent with minimal protein from highly infectious cultures.

Authors:  Ru Sun; Ying Liu; He Zhang; Laura Manuelidis
Journal:  Viral Immunol       Date:  2008-09       Impact factor: 2.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.